Simon Manwaring Robertson

The Economist Newspaper Group, Inc. publishes magazines and newspapers. It delivers its information through a range of formats, from newspapers and magazines to conferences and electronic services. The company was founded in 1843 and is headquartered in New York, NY.

Royal Opera House Covent Garden Foundation venue for theatrical productions, operas and plays. The company is headquartered in London, the United Kingdom.

The Economist Newspaper Ltd. engages in the publication of financial journals, magazines and online publications. It operates thorugh the following brands: The Economist brand family, EuroFinance, BrandConnect, Ideas People Media, TVC, and Signal Noise. The company was founded by James Wilson in 1843 and is headquartered in London, The United Kingdom.

The Economist Newspaper Group, Inc. publishes magazines and newspapers. It delivers its information through a range of formats, from newspapers and magazines to conferences and electronic services. The company was founded in 1843 and is headquartered in New York, NY.

The Economist Newspaper Ltd. engages in the publication of financial journals, magazines and online publications. It operates thorugh the following brands: The Economist brand family, EuroFinance, BrandConnect, Ideas People Media, TVC, and Signal Noise. The company was founded by James Wilson in 1843 and is headquartered in London, The United Kingdom.

The Economist Newspaper Group, Inc. publishes magazines and newspapers. It delivers its information through a range of formats, from newspapers and magazines to conferences and electronic services. The company was founded in 1843 and is headquartered in New York, NY.

Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The private company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022.

Royal Opera House Covent Garden Foundation venue for theatrical productions, operas and plays. The company is headquartered in London, the United Kingdom.

Royal Opera House Covent Garden Foundation venue for theatrical productions, operas and plays. The company is headquartered in London, the United Kingdom.

Royal Opera House Covent Garden Foundation venue for theatrical productions, operas and plays. The company is headquartered in London, the United Kingdom.

Royal Opera House Covent Garden Foundation venue for theatrical productions, operas and plays. The company is headquartered in London, the United Kingdom.

Royal Opera House Covent Garden Foundation venue for theatrical productions, operas and plays. The company is headquartered in London, the United Kingdom.

Royal Opera House Covent Garden Foundation venue for theatrical productions, operas and plays. The company is headquartered in London, the United Kingdom.

Royal Opera House Covent Garden Foundation venue for theatrical productions, operas and plays. The company is headquartered in London, the United Kingdom.